ArticleOncoimmunology2020

In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma.

Bas D Koster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.